-
EP4257123
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4257123
| EP4257123 - STABLE ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.09.2023 Database last updated on 03.09.2024 | |
| Former | The international publication has been made Status updated on 14.06.2022 | Most recent event Tooltip | 09.04.2024 | Supplementary search report | published on 08.05.2024 [2024/19] | Applicant(s) | For all designated states LG Chem, Ltd. 128 Yeoui-daero Yeongdeungpo-gu Seoul 07336 / KR | [N/P] |
| Former [2023/41] | For all designated states Lg Chem, Ltd. 128 Yeoui-daero Yeongdeungpo-gu Seoul 07336 / KR | Inventor(s) | 01 /
YOO, Seok Cheol Daejeon 34122 / KR | 02 /
LEE, Sun Daejeon 34122 / KR | 03 /
YUN, Duck Il Daejeon 34122 / KR | 04 /
PARK, Junghong Daejeon 34122 / KR | 05 /
SUN, Hyun Ji Daejeon 34122 / KR | [2023/41] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2023/41] | Application number, filing date | 21900957.8 | 30.11.2021 | [2023/41] | WO2021KR17842 | Priority number, date | KR20200166051 | 01.12.2020 Original published format: KR 20200166051 | [2023/41] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022119269 | Date: | 09.06.2022 | Language: | KO | [2022/23] | Type: | A1 Application with search report | No.: | EP4257123 | Date: | 11.10.2023 | Language: | EN | [2023/41] | Search report(s) | International search report - published on: | KR | 09.06.2022 | (Supplementary) European search report - dispatched on: | EP | 08.04.2024 | Classification | IPC: | A61K9/20, A61K31/4155, A61P19/06 | [2023/41] | CPC: |
A61P19/06 (EP,KR);
A61K9/2054 (EP,KR,US);
A61K31/4155 (EP,KR,US);
A61K9/2009 (US);
A61K9/2013 (KR,US);
A61K9/2018 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/41] | Title | German: | STABILE ORALE FORMULIERUNG MIT 1-(3-CYANO-1-ISOPROPYL-5-YL)PYRAZOL-4-CARBONSÄURE | [2023/41] | English: | STABLE ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | [2023/41] | French: | FORMULATION ORALE STABLE CONTENANT DE L'ACIDE 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIQUE | [2023/41] | Entry into regional phase | 06.06.2023 | Translation filed | 06.06.2023 | National basic fee paid | 06.06.2023 | Search fee paid | 20.06.2023 | Designation fee(s) paid | 20.06.2023 | Examination fee paid | Examination procedure | 20.06.2023 | Examination requested [2023/41] | Fees paid | Renewal fee | 22.11.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2012138147 (LG LIFE SCIENCES LTD [KR], et al); | [XD]KR101751325B ; | [E]EP4218755 (LG CHEMICAL LTD [KR]) | International search | [A]WO2004010973 (PHARMACIA CORP [US], et al); | [A]JP2008523109 ; | [A]KR20090128488 (KISSEI PHARMACEUTICAL [JP]); | [DA]KR20110037883 (LG LIFE SCIENCES LTD [KR]); | [DA]KR20120114174 (LG LIFE SCIENCES LTD [KR]) | by applicant | KR200166051 | KR101424013B | KR101751325B |